2024
Conference Contribution - Verbal presentation and other Conference outputs
van der Werf, J., Chin, C. V., Schultz, M., Dunbier, A., & Fleming, N. (2024, August-September). Influence of SNP rs1800795 on macrophage polarisation, colitis, and response to emerging therapies. Verbal presentation at the Queenstown Research Week (QRW) Cancer Meeting, Queenstown, New Zealand.
2023
Journal - Research Article
McGuinness, C. F., Black, M. A., & Dunbier, A. K. (2023). Restriction site associated DNA sequencing for tumour mutation burden estimation and mutation signature analysis. Cancer Medicine. Advance online publication. doi: 10.1002/cam4.6711
Conference Contribution - Published proceedings: Abstract
van der Werf, J., Chin, C. V., Dunbier, A., & Fleming, N. (2023). Influence of SNP rs1800795 on macrophage polarisation, colitis, and response to emerging therapies. Proceedings of the Graduate Research Student Symposium. (pp. 26). Retrieved from https://www.otago.ac.nz/graduate-research
van der Werf, J., Chin, C. V., Dunbier, A., & Fleming, N. (2023). Influence of SNP rs1800795 on macrophage polarisation, colitis, and response to emerging therapies. Proceedings of the Genetics Otago (GO) Annual Symposium & Workshops. Retrieved from https://blogs.otago.ac.nz/go
Bull, D., Hazlett, J., McLellan, A., & Dunbier, A. (2023). Development and characterisation of immunocompetent models for metastatic oestrogen receptor positive breast cancer. Molecular Oncology, 17(Suppl. 1), (pp. 513-514). doi: 10.1002/1878-0261.13471
2022
Conference Contribution - Published proceedings: Abstract
Bull, D., Hazlett, J., McLellan, A., & Dunbier, A. (2022). Investigating the role of immunotherapy in the treatment of metastatic oestrogen receptor positive breast cancer. Proceedings of the Genetics Otago (GO) Annual Symposium. Retrieved from https://blogs.otago.ac.nz/go
Siemonek, A., Van Huffel, S., Gimenez, G., Weeks, R., Horsfield, J. A., Antony, J., & Dunbier, A. (2022). Unraveling the mechanisms involved in the co-regulation of breast cancer associated genes at the 6q25.1 locus. Proceedings of the Genetics Otago (GO) Annual Symposium. Retrieved from https://blogs.otago.ac.nz/go
McGuinness, C. F., Black, M., & Dunbier, A. K. (2022). RADseq for tumour mutation burden estimation and mutation signature analysis. Annals of Oncology, 33(Suppl. 8), (pp. S1415). doi: 10.1016/j.annonc.2022.09.106
Conference Contribution - Verbal presentation and other Conference outputs
McGuinness, C., Black, M. A., & Dunbier, A. K. (2022, August). A novel mechanism for APOBEC mutagenesis in carriers of the APOBEC3B deletion polymorphism. Verbal presentation at the Cancer Satellite Meeting: Queenstown Research Week, Queenstown, New Zealand.
2021
Journal - Research Article
Hazlett, J., Niemi, V., Aiderus, A., Powell, K., Wise, L., Kemp, R., & Dunbier, A. K. (2021). Oestrogen deprivation induces chemokine production and immune cell recruitment in in vitro and in vivo models of oestrogen receptor-positive breast cancer. Breast Cancer Research, 23, 95. doi: 10.1186/s13058-021-01472-1
Wiggins, G. A. R., Black, M. A., Dunbier, A., Morley-Bunker, A. E., kConFab Investigators, Pearson, J. F., & Walker, L. C. (2021). Increased gene expression variability in BRCA1-associated and basal-like breast tumours. Breast Cancer Research & Treatment, 189, 363-375. doi: 10.1007/s10549-021-06328-y
Wiggins, G. A. R., Black, M. A., Dunbier, A., Merriman, T. R., Pearson, J. F., & Walker, L. C. (2021). Variable expression quantitative trait loci analysis of breast cancer risk variants. Scientific Reports, 11(1), 7192. doi: 10.1038/s41598-021-86690-5
Journal - Research Other
McMillan, H. D., Keeshan, K., Dunbier, A. K., & Mace, P. D. (2021). Structure vs. function of TRIB1: Myeloid neoplasms and beyond. Cancer, 13, 3060. doi: 10.3390/cancers13123060
Conference Contribution - Published proceedings: Abstract
Siemonek, A., Van Huffel, S., Gimenez, G., Horsfield, J. A., Antony, J., & Dunbier, A. (2021). Unraveling the mechanisms involved in the co-regulation of breast cancer associated genes at the 6q25.1 locus. Proceedings of the Genetics Otago (GO) Annual Symposium. Retrieved from https://blogs.otago.ac.nz/go
Bull, D., Hazlett, J., McLellan, A., & Dunbier, A. (2021). Investigating the role of immunotherapy in the treatment of metastatic oestrogen receptor positive breast cancer. Proceedings of the Genetics Otago (GO) Annual Symposium. Retrieved from https://blogs.otago.ac.nz/go
2020
Conference Contribution - Published proceedings: Abstract
Wiggins, G., Pearson, J., Black, M., Dunbier, A., Merriman, T., & Walker, L. (2020). Variable expression quantitative trait loci analysis of breast cancer risk variants. New Zealand Medical Journal, 133(1524), (pp. 145). Retrieved from https://www.nzma.org.nz/journal
Dunbier, A. K., Hazlett, J. A., Powell, K., Niemi, G., & Kemp, R. (2020). Investigation of combination treatment an aromatase inhibitor and anti-inflammatory treatment in a model of oestrogen receptor positive breast cancer. Cancer Research, 80(4, Suppl.), P1-03-07. doi: 10.1158/1538-7445.Sabcs19-p1-03-07
2018
Journal - Research Article
Jamieson, S. A., Ruan, Z., Burgess, A. E., Curry, J. R., McMillan, H. D., Brewster, J. L., Dunbier, A. K., … Mace, P. D. (2018). Substrate binding allosterically relieves autoinhibition of the pseudokinase TRIB1. Science Signaling, 11(549), eaau0597. doi: 10.1126/scisignal.aau0597
Aiderus, A., Black, M. A., & Dunbier, A. K. (2018). Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers. BMC Cancer, 18, 805. doi: 10.1186/s12885-018-4626-9
Conference Contribution - Published proceedings: Abstract
McGuinness, C., & Dunbier, A. (2018). Quantifying PD-L1 expression in response to oestrogen deprivation in oestrogen receptor positive breast cancer. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/
Hazlett, J., Niemi, G., Kemp, R., & Dunbier, A. (2018). Investigation of combination treatment an aromatase inhibitor and anti-inflammatory treatment in a model of oestrogen receptor positive breast cancer. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/
Wiggins, G., Pearson, J., Black, M., Dunbier, A., & Walker, L. (2018). Expression variability is associated with breast tumour subtype. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/
Powell, K., Hazlett, J., & Dunbier, A. (2018). Combination treatment with letrozole and immune checkpoint inhibitors decreases tumour growth in a murine model of oestrogen receptor positive breast cancer. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/
McMillan, H., Mace, P., & Dunbier, A. (2018). The role of pseudokinase TRIB1 in breast cancer. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/
Conference Contribution - Poster Presentation (not in published proceedings)
McGuinness, C., & Dunbier, A. (2018, August). Quantifying PD-L1 expression in response in oestrogen deprivation in oestrogen receptor positive breast cancer. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
Wiggins, G., Pearson, J., Black, M., Dunbier, A., & Walker, L. (2018, August). Expression variability is associated with breast tumour subtype. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
McMillan, H., Mace, P., & Dunbier, A. (2018, August). The role of pseudokinase TRIB1 in breast cancer. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
Conference Contribution - Verbal presentation and other Conference outputs
Hazlett, J., Niemi, G., Kemp, R., & Dunbier, A. (2018, August). Investigation of combination treatment of an aromatase inhibitor and anti-inflammatory treatment in a model of oestrogen receptor positive breast cancer. Verbal presentation at the Queenstown Molecular Biology (QMB) and Australasian Society for Immunology New Zealand Branch (ASI-NZ) Joint Meeting, Queenstown, New Zealand.
2017
Journal - Research Article
Prat, A., Lluch, A., Turnbull, A. K., Dunbier, A. K., Calvo, L., Albanell, J., … Alba, E. (2017). A PAM50-based chemoendocrine score for hormone receptor-positive breast cancer with an intermediate risk of relapse. Clinical Cancer Research, 23(12). doi: 10.1158/1078-0432.ccr-16-2092
Conference Contribution - Published proceedings: Abstract
Hazlett, J., Hunter, B., Kemp, R., & Dunbier, A. (2017). Investigating immune responsiveness in oestrogen receptor positive breast cancer. In A. Blackman, L. Gillman, C. Oliver & D. Dantzic (Eds.), Proceedings of the Inaugural New Zealand Breast Cancer Symposium (NZBCS): United for a Cure through Research. (pp. 52). Auckland, New Zealand: Auckland University of Technology. [Abstract]
Pearson, J. F., Wiggins, G. A. R., Black, M., Dunbier, A., & Walker, L. C. (2017). Expression variability is associated with breast cancer tumour subtype. Proceedings of the American Society of Human Genetics (ASHG) Annual Meeting. 746. Retrieved from http://www.ashg.org/2017meeting/
Flaherty, S., Taiaroa, G., & Dunbier, A. (2017). Identifying cancer-associated mutations within the New Zealand population using high-resolution melting. New Zealand Medical Journal, 130(1461), (pp. 90). Retrieved from http://www.nzma.org.nz/journal
Conference Contribution - Verbal presentation and other Conference outputs
Aiderus, A., Black, M., & Dunbier, A. (2017, September). Insights into the prognostic association of fatty acid oxidation in cancer. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
Dunbier, A. K., van Huffel, S., Day, R., & Horsfield, J. (2017, September). Epigenetic regulation of genes associated with breast cancer risk and progression. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
Dunbier, A., Hazlett, J., Wise, L., & Kemp, R. (2017, July). Effect of oestrogen deprivation on chemokine expression and immune cell recruitment in breast cancer. Verbal presentation at the New Zealand Branch of the Australasian Society for Immunology (NZ ASI) Annual Scientific Meeting, Christchurch, New Zealand.
2016
Conference Contribution - Published proceedings: Abstract
van Huffel, S., Day, R. C., Antony, J., Marsman, J., Horsfield, J. A., & Dunbier, A. K. (2016). 4CSeq analysis of a breast cancer susceptibility locus on 6q25.1. Cancer Research, 76(14, Suppl.), 4518. doi: 10.1158/1538-7445.AM2016-4518
Bin Aiderus, A. A., Black, M. A., & Dunbier, A. K. (2016). Expression of metabolic genes is associated with prognosis in breast cancer. Molecular Cancer Research, 14(1, Suppl.), A44. doi: 10.1158/1557-3125.metca15-a44
Conference Contribution - Verbal presentation and other Conference outputs
Wiggins, G. A. R., Pearson, J., Dunbier, A., Black, M., & Walker, L. (2016, August-September). Gene expression variability in breast tumours. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Nelson, New Zealand.
2015
Journal - Research Article
Turnbull, A. K., Arthur, L. M., Renshaw, L., Larionov, A. A., Kay, C., Dunbier, A. K., … Dixon, J. M. (2015). Accurate prediction and validation of response to endocrine therapy in breast cancer. Journal of Clinical Oncology, 33(20), 2270-2278. doi: 10.1200/jco.2014.57.8963
López-Knowles, E., Wilkerson, P. M., Ribas, R., Anderson, H., Mackay, A., Ghazoui, Z., … Dunbier, A. K., … Dowsett, M. (2015). Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer. Breast Cancer Research, 17, 35. doi: 10.1186/s13058-015-0532-0
Conference Contribution - Verbal presentation and other Conference outputs
Dunbier, A. K., Hazlett, J. A., Hunter, B. L., Buchanan, S. T., Bundock, A. S., Wise, L. M., Kemp, R. A., & Dowsett, M. (2015, August-September). Determinants of resistance to endocrine therapy in breast cancer. Verbal presentation at the Medical Sciences Congress (MedSci), Queenstown, New Zealand.
Dunbier, A. (2015, August-September). Epigenetic regulation of genes associated with breast cancer risk and progression. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
2014
Journal - Research Article
Ribas, R., Ghazoui, Z., Gao, Q., Pancholi, S., Rani, A., Dunbier, A., … Martin, L.-A. (2014). Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor–positive breast cancers. Breast Cancer Research, 16, 447. doi: 10.1186/s13058-014-0447-1
Patani, N., Dunbier, A. K., Anderson, H., Ghazoui, Z., Ribas, R., Anderson, E., … Dowsett, M. (2014). Differences in the transcriptional response to fulvestrant and estrogen deprivation in ER-positive breast cancer. Clinical Cancer Research, 20(15), 3962-3973. doi: 10.1158/1078-0432.ccr-13-1378
Gao, Q., Patani, N., Dunbier, A. K., Ghazoui, Z., Zvelebil, M., Martin, L.-A., & Dowsett, M. (2014). Effect of aromatase inhibition on functional gene modules in estrogen receptor–positive breast cancer and their relationship with antiproliferative response. Clinical Cancer Research, 20(9), 2485-2494. doi: 10.1158/1078-0432.CCR-13-2602
Conference Contribution - Published proceedings: Abstract
White, J., van Huffel, S., Antony, J., Horsfield, J. A., & Dunbier, A. K. (2014). Expression of genes spanning a breast cancer susceptibility locus on 6q25.1 is modulated by epigenetic modification. Cancer Research, 74(19, Suppl.), 403. doi: 10.1158/1538-7445.AM2014-403
Conference Contribution - Verbal presentation and other Conference outputs
Dunbier, A. (2014, August). Jekyll or Hyde: Immune responses and anti-oestrogen therapy in breast cancer? Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
2013
Journal - Research Article
Sgroi, D. C., Sestak, I., Cuzick, J., Zhang, Y., Schnabel, C. A., Schroeder, B., … Dunbier, A., … Dowsett, M. (2013). Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: A prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population. Lancet Oncology, 14, 1067-1076. doi: 10.1016/S1470-2045(13)70387-5
Dowsett, M., Sestak, I., Lopez-Knowles, E., Sidhu, K., Dunbier, A. K., Cowens, J. W., … Cuzick, J. (2013). Comparison of PAM50 risk of recurrence score with Oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy. Journal of Clinical Oncology, 31(22), 2783-2790. doi: 10.1200/jco.2012.46.1558
Dunbier, A. K., Ghazoui, Z., Anderson, H., Salter, J., Nerurkar, A., Osin, P., … Dowsett, M. (2013). Molecular profiling of aromatase inhibitor-treated post-menopausal breast tumors identifies immune-related correlates of resistance. Clinical Cancer Research, 19(10), 2775-2786. doi: 10.1158/1078-0432.ccr-12-1000
Conference Contribution - Published proceedings: Abstract
Dunbier, A., Anderson, H., Hazlett, J., Hunter, B., & Dowsett, M. (2013). Molecular predictors of response to aromatase inhibitor treatment in breast cancer. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/conference_2013
Conference Contribution - Poster Presentation (not in published proceedings)
Hunter, B., Petrich, S., & Dunbier, A. (2013, July). Investigation of leukocyte composition of breast cancer. Poster session presented at the New Zealand Society for Oncology Conference, Dunedin, New Zealand.
2012
Journal - Research Article
Weigel, M. T., Ghazoui, Z., Dunbier, A. K., Pancholi, S., Dowsett, M., & Martin, L.-A. (2012). Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer. Breast Cancer Research, 14(3), R78. doi: 10.1186/bcr3191
Conference Contribution - Published proceedings: Abstract
Dunbier, A. K., White, J., & Van Huffel, S. (2012). Expression of genes spanning a breast cancer susceptibility locus on 6q25.1 is modulated by epigenetic modification. Cancer Research, 72(24, Suppl 3), (pp. 1187). doi: 10.1158/0008-5472.SABCS12-P4-06-11
Hunter, B., & Dunbier, A. (2012). Upregulation of chemokine expression is associated with oestrogen deprivation in ER+ breast cancer. New Zealand Medical Journal, 125(1355). Retrieved from http://www.nzma.org.nz/journal
Conference Contribution - Poster Presentation (not in published proceedings)
White, J., & Dunbier, A. (2012, September). Regulatory mechanisms leading to the co-expression of ESR1 and three uncharacterised genes in a breast cancer susceptibility locus. Poster session presented at the Division of Health Sciences Research Forum: Health Matters: Research Excellence at Otago, Dunedin, New Zealand.
White, J., & Dunbier, A. (2012, August). Regulatory mechanisms leading to the co-expression of ESR1 and three uncharacterised genes at the 6q25.1 breast cancer susceptibility locus. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
Van Huffel, S., & Dunbier, A. (2012, August). Functional study of uncharacterized genes co-expressed with ESR1. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
Conference Contribution - Verbal presentation and other Conference outputs
Dunbier, A. K., Hazlett, J., Hunter, B., & Dowsett, M. (2012, November). Cancer pharmacogenomics. Verbal presentation at the 8th Annual Carney Pharmacogenomics Symposium, Christchurch, New Zealand.
Dunbier, A. (2012, September). Understanding resistance to therapy in breast cancer. Verbal presentation at the Division of Health Sciences Research Forum: Health Matters: Research Excellence at Otago, Dunedin, New Zealand.
Dunbier, A. K. (2012, August). Molecular mechanisms of resistance to therapy in breast cancer. Invited presentation at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
2011
Journal - Research Article
Dowsett, M., Smith, I., Robertson, J., Robison, L., Pinhel, I., Johnson, L., … Dunbier, A., … Bliss, J. (2011). Endocrine therapy, new biologicals, and new study designs for presurgical studies in breast cancer. Journal of the National Cancer Institute Monographs, 43, 120-123. doi: 10.1093/jncimonographs/lgr034
Miller, T. W., Balko, J. M., Fox, E. M., Ghazoui, Z., Dunbier, A., Anderson, H., … Arteaga, C. L. (2011). ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer. Cancer Discovery, 1, 338-351. doi: 10.1158/2159-8290.CD-11-0101
Martin, L.-A., Ghazoui, Z., Weigel, M. T., Pancholi, S., Dunbier, A., Johnston, S., & Dowsett, M. (2011). An in vitro model showing adaptation to long-term oestrogen deprivation highlights the clinical potential for targeting kinase pathways in combination with aromatase inhibition. Steroids, 76, 772-776. doi: 10.1016/j.steroids.2011.02.035
Miller, T. W., Balko, J. M., Ghazoui, Z., Dunbier, A., Anderson, H., Dowsett, M., … Arteaga, C. L. (2011). A gene expression signature from human breast cancer cells with acquired hormone independence identifies MYC as a mediator of antiestrogen resistance. Clinical Cancer Research, 17(7), 2024-2034. doi: 10.1158/1078-0432.ccr-10-2567
Lønning, P. E., Haynes, B. P., Straume, A. H., Dunbier, A., Helle, H., Knappskog, S., & Dowsett, M. (2011). Recent data on intratumor estrogens in breast cancer. Steroids, 76(8), 786-791. doi: 10.1016/j.steroids.2011.02.040
Lønning, P. E., Haynes, B. P., Straume, A. H., Dunbier, A., Helle, H., Knappskog, S., & Dowsett, M. (2011). Exploring breast cancer estrogen disposition: The basis for endocrine manipulation. Clinical Cancer Research, 17(15), 4948-4958. doi: 10.1158/1078-0432.ccr-11-0043
Ghazoui, Z., Buffa, F. M., Dunbier, A. K., Anderson, H., Dexter, T., Detre, S., … Dowsett, M. (2011). Close and stable relationship between proliferation and a hypoxia metagene in aromatase inhibitor-treated ER-positive breast cancer. Clinical Cancer Research, 17(9), 3005-3012. doi: 10.1158/1078-0432.ccr-10-1704
Dunbier, A. K., Martin, L.-A., & Dowsett, M. (2011). New and translational perspectives of oestrogen deprivation in breast cancer. Molecular & Cellular Endocrinology, 340(2), 137-141. doi: 10.1016/j.mce.2010.12.034
Dunbier, A. K., Anderson, H., Ghazoui, Z., Salter, J., Parker, J. S., Perou, C. M., … Dowsett, M. (2011). Association between breast cancer subtypes and response to neoadjuvant anastrozole. Steroids, 76(8), 736-740. doi: 10.1016/j.steroids.2011.02.025
Dunbier, A. K., Anderson, H., Ghazoui, Z., Lopez-Knowles, E., Pancholi, S., Ribas, R., … Dowsett, M. (2011). ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1. PLoS Genetics, 7(4), e1001382. doi: 10.1371/journal.pgen.1001382
Conference Contribution - Published proceedings: Abstract
Dunbier, A. K., Ghazoui, Z., Anderson, H., Nerurkar, A., Osin, P., Smith, I., & Dowsett, M. (2011). Mechanistic understanding. Annals of Oncology, 22(Suppl. 2), (pp. ii20). doi: 10.1093/annonc/mdr074
Weigel, M. T., Banerjee, S., A’Hern, R., Arnedos, M., Ghazoui, Z., Dunbier, A. K., … Martin, L.-A. (2011). Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming resistance. Cancer Research, 71(24, Suppl. 3), P4-01-01. doi: 10.1158/0008-5472.SABCS11-P4-01-01
2010
Journal - Research Article
Dunbier, A. K., Anderson, H., Ghazoui, Z., Folkerd, E. J., A’Hern, R., Crowder, R. J., … Dowsett, M. (2010). Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women. Journal of Clinical Oncology, 28(7), 1161-1167. doi: 10.1200/JCO.2009.23.9616
Dowsett, M., Cuzick, J., Wale, C., Forbes, J., Mallon, E. A., Salter, J., … Dunbier, A., … Shak, S. (2010). Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: A TransATAC study. Journal of Clinical Oncology, 28(11), 1829-1834. doi: 10.1200/JCO.2009.24.4798
Journal - Research Other
Dunbier, A. K., Hong, Y., Masri, S., Brown, K. A., Sabnis, G. J., & Palomares, M. R. (2010). Progress in aromatase research and identification of key future directions. Journal of Steroid Biochemistry & Molecular Biology, 118(4-5), 311-315. doi: 10.1016/j.jsbmb.2009.09.005
Conference Contribution - Published proceedings: Abstract
Ghazoui, Z., Weigel, M. T., Anderson, H., Dunbier, A., Dowsett, M., & Martin, L.-A. (2010). Temporal changes of gene expression in breast cancer cells during adaptation to estrogen deprivation highlight the clinical potential for targeting kinase pathways. Cancer Research, 70(8, Suppl. 1), 4598. doi: 10.1158/1538-7445.AM10-4598
Weigel, M. T., Ghazoui, Z., Lykkesfeldt, A. E., Anderson, H., Dunbier, A., Mundhenke, C., … Martin, L.-A. (2010). Experimental and clinical studies reveal the PDGF/Abl pathway as a novel therapeutic target in endocrine-resistant breast cancer. Cancer Research, 70(8, Suppl. 1), 2920. doi: 10.1158/1538-7445.AM10-2920
Dunbier, A., Anderson, H., Ghazoui, Z., Pancholi, S., Sidhu, K., Leary, A., … Dowsett, M. (2010). Novel genes closely adjacent to and coexpressed with ESR1 affect proliferation in ER+ve breast tumors. Cancer Research, 70(8, Suppl. 1), 2916. doi: 10.1158/1538-7445.AM10-2916
Ghazoui, Z., Anderson, H., Dunbier, A., Anderson, E., Lindemann, J., Wellings, B., … Dowsett, M. (2010). Transcriptional changes induced by anastrozole and fulvestrant treatment in ER-positive breast cancers. Cancer Research, 70(24, Suppl. 2), P1-12-02. doi: 10.1158/0008-5472.SABCS10-P1-12-02
Dunbier, A. K., Ghazoui, Z., Anderson, H., Smith, I. E., & Dowsett, M. (2010). Molecular profiling of aromatase inhibitor-treated post-menopausal breast tumours identifies determinants of response. Cancer Research, 70(24, Suppl. 2), S2-5. doi: 10.1158/0008-5472.SABCS10-S2-5
2009
Conference Contribution - Published proceedings: Abstract
Drury, S., Johnson, N., Hills, M., Salter, J., Afentakis, M., Dunbier, A., … and FACE Trialists. (2009). A breast cancer-associated SNP adjacent to ESR1 correlates with Oestrogen Receptor-α (ERα) level in invasive breast tumours. Cancer Research, 69(24, Suppl. 3), 4138. doi: 10.1158/0008-5472.SABCS-09-4138
Dunbier, A. K., Anderson, H., Folkerd, E., Ghazoui, Z., Smith, I. E., Ellis, M. J., … and Neoadjuvant Letrozole Study Group. (2009). Expression of estrogen responsive genes in breast cancers correlates with plasma estradiol levels in postmenopausal women. Cancer Research, 69(2, Suppl. 1), 63. doi: 10.1158/0008-5472.SABCS-63
Ghazoui, Z., Buffa, F., Dunbier, A., Anderson, H., Dexter, T., Smith, I., … Dowsett, M. (2009). Aromatase inhibitors reduce the expression of a hypoxia metagene in oestrogen receptor positive breast cancer in postmenopausal women. Cancer Research, 69(24, Suppl. 3), 408. doi: 10.1158/0008-5472.SABCS-09-408
Dowsett, M., Dunbier, A., Anderson, H., Salter, J., Detre, S., Jones, R., … Smith, I. E. (2009). Biomarkers and predictive factors of response to neoadjuvant treatment. Breast Cancer Research, 11(Suppl. 1), S11. doi: 10.1186/bcr2272
2008
Journal - Research Article
Kendall, A., Anderson, H., Dunbier, A. K., Mackay, A., Dexter, T., Urruticoechea, A., … Dowsett, M. (2008). Impact of estrogen deprivation on gene expression profiles of normal postmenopausal breast tissue in vivo. Cancer Epidemiology, Biomarkers & Prevention, 17(4), 855-863. doi: 10.1158/1055-9965.epi-07-2718
Dowsett, M., & Dunbier, A. K. (2008). Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer. Clinical Cancer Research, 14(24), 8019-8026. doi: 10.1158/1078-0432.ccr-08-0974
Humar, B., McNoe, L., Dunbier, A., Heathcott, R., Braithwaite, A. W., & Reeve, A. E. (2008). Heterogeneous gene expression changes in colorectal cancer cells share the WNT pathway in response to growth suppression by APHS-mediated COX-2 inhibition. Biologics, 2(2), 329-337.
Nasri, S., More, H., Graziano, F., Ruzzo, A., Wilson, E., Dunbier, A., McKinney, C., Merriman, T., Guilford, P., … Humar, B. (2008). A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: A case control study in an Italian population. BMC Cancer, 8, 138. doi: 10.1186/1471-2407-8-138
2007
Journal - Research Article
Humar, B., Fukuzawa, R., Blair, V., Dunbier, A., More, H., Charlton, A., … Reeve, A. E., … Guilford, P. (2007). Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer. Cancer Research, 67(6), 2480-2489. doi: 10.1158/0008-5472.CAN-06-3021
2006
Conference Contribution - Published proceedings: Abstract
Humar, B., Fukuzawa, R., Blair, V., Dunbier, A., More, H., Charlton, A., Reeve, A., … Guilford, P. (2006). The early development of diffuse gastric cancer. Differentiation. 74(8), (pp. 455). [Abstract]
2005
Conference Contribution - Published proceedings: Abstract
Dunbier, A. K., & Guilford, P. J. (2005). E-cadherin loss has a permissive but not active role in gastric cancer. Proceedings of the American Association for Cancer Research (AACR) 96th Annual Meeting. Retrieved from http://www.aacrmeetingabstracts.org/
Conference Contribution - Poster Presentation (not in published proceedings)
Heathcott, R. W., Fukuzawa, R., Dunbier, A. K., McNoe, L., & Reeve, A. E. (2005, August). Myogenesis in Wilms tumors is associated with the WNT signalling pathway. Poster session presented at the 15th Annual Queenstown Molecular Biology Meeting, Queenstown, New Zealand.
2003
Journal - Research Article
da Silva Tatley, F. M., Aldwell, F., Dunbier, A. K., & Guilford, P. J. (2003). N-terminal E-cadherin peptides act as decoy receptors for Listeria monocytogenes. Infection & Immunity, 71(3), 1580-1583.
2002
Chapter in Book - Research
Dunbier, A. K., & Guilford, P. J. (2002). Gastric cancer: Inherited predisposition. In S. R. Hamilton & L. A. Aaltonen (Eds.), Encyclopedia of Cancer, Volume 2. (2nd ed.) (pp. 253-258). USA: Elsevier Science.
Dunbier, A. K., & Guilford, P. J. (2002). Gastric cancer: Inherited predisposition. In J. R. Bertino (Ed.), Encyclopedia of cancer. (2nd ed.) (pp. 253-258). Academic Press. [Encyclopaedia/Dictionary Entry].
2001
Journal - Research Article
Dunbier, A. K., & Guilford, P. J. (2001). Hereditary diffuse gastric cancer. Advances in Cancer Research, 83, 55-65.
2000
Journal - Research Article
Grady, W. M., Willis, J., Guilford, P. J., Dunbier, A. K., Toro, T. T., Lynch, H., … Markowitz, S. D. (2000). Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nature Genetics, 26, 16-17.